Pfizer – 2022/2023 Global Obesity ASPIRE competitive Grant Program – using Expert Review Panel – LOI

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research program. An ISR grant request cannot be submitted for a study that has already commenced and was not originally supported by Pfizer.

• • RFP release date: August 22, 2022
• • Letter of Intent (LOI) due date: October 11, 2022 [Please note the deadline is 23:59 Eastern Time (New York, GMT -5).]
• • Review of LOIs by ERP: December 2022
• • Anticipated LOI Notification Date: January 2023
• • Full Proposal Deadline: *February 2023 *Only accepted LOIs will be invited to submit full proposals [Please note the deadline is 23:59 Eastern Time (New York, GMT -5).]

Link to full RFP: 2022/2023 Global Obesity ASPIRE